Correction: Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes
✍ Scribed by Granucci, Francesca; Vizzardelli, Caterina; Pavelka, Norman; Feau, Sonia; Persico, Maria; Virzi, Ettore; Rescigno, Maria; Moro, Giorgio; Ricciardi-Castagnoli, Paola
- Book ID
- 109921660
- Publisher
- Nature Publishing Group
- Year
- 2001
- Tongue
- English
- Weight
- 15 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1529-2908
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Type 1 (insulin-dependent) diabetic patients and control subjects of Afro-Caribbean Negroid racial origin were investigated by serological HLA-DR-typing and restriction fragment length polymorphism analysis using DNA probes corresponding to the DQ alpha, DQ beta and DR beta chain genes. Combined ana
HLA-DR and MT1, MT2, MT3 genotypes have been investigated in 123 Type 1 (insulin-dependent) diabetic subjects and their families. Ninety-eight percent of probands possessed either DR3 (relative risk = 5.0), or DR4 (relative risk = 6.8) or both antigens (relative risk = 14.3), emphasizing the strong
## Abstract ## Background Mutating the insulin B:9–23 peptide prevents diabetes in NOD mice. Thus, the trimolecular complex of I‐A$^{\rm{g7}}$‐insulin B:9–23 peptide‐TCR may be essential for the development of spontaneous diabetes. Pathogenic T cells recognize the B:9–23 peptide presented by I‐A$^